Girard Partners Ltd. Incyte Corp Transaction History

Girard Partners Ltd.

$1.06 Billion
Q2 2024

A detailed history of Girard Partners Ltd. transactions in Incyte Corp stock. As of the latest transaction made, Girard Partners Ltd. holds 49,711 shares of INCY stock, worth $3.66 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

49,711

Previous 49,738 0.05%

Holding current value

$3.66 Million

Previous $2.83 Million 6.35%

% of portfolio

0.29%

Previous 0.27%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$51.18 - $63.75 $1,381 - $1,721	-27 Reduced 0.05%	49,711 $3.01 Million
Q1 2024 May 13, 2024	BUY	$56.55 - $66.59 $800,917 - $943,114	14,163 Added 39.81%	49,738 $2.83 Million
Q4 2023 Feb 09, 2024	SELL	$52.16 - $64.19 $236,754 - $291,358	-4,539 Reduced 11.32%	35,575 $2.23 Million
Q3 2023 Nov 02, 2023	BUY	$57.77 - $65.93 $1.1 Million - $1.25 Million	19,021 Added 90.18%	40,114 $2.32 Million
Q2 2023 Aug 15, 2023	BUY	$60.95 - $75.51 $302,007 - $374,152	4,955 Added 30.7%	21,093 $1.31 Million
Q1 2023 May 12, 2023	SELL	$70.23 - $86.01 $21,139 - $25,889	-301 Reduced 1.83%	16,138 $1.17 Million
Q4 2022 Jan 26, 2023	BUY	$67.18 - $84.11 $17,265 - $21,616	257 Added 1.59%	16,439 $0
Q3 2022 Oct 20, 2022	SELL	$66.18 - $82.86 $56,054 - $70,182	-847 Reduced 4.97%	16,182 $1.08 Million
Q2 2022 Jul 26, 2022	SELL	$66.18 - $83.18 $11,515 - $14,473	-174 Reduced 1.01%	17,029 $1.29 Million
Q1 2022 Apr 27, 2022	BUY	$66.02 - $79.71 $206,642 - $249,492	3,130 Added 22.24%	17,203 $1.37 Million
Q4 2021 Feb 02, 2022	SELL	$63.34 - $74.11 $615,601 - $720,275	-9,719 Reduced 40.85%	14,073 $1.03 Million
Q3 2021 Nov 01, 2021	BUY	$68.67 - $84.02 $1.52 Million - $1.86 Million	22,156 Added 1354.28%	23,792 $1.64 Million
Q3 2021 Nov 01, 2021	SELL	$68.67 - $84.02 $1.38 Million - $1.69 Million	-20,056 Reduced 92.46%	1,636 $1.64 Million
Q2 2021 Aug 10, 2021	BUY	$79.87 - $87.53 $147,440 - $161,580	1,846 Added 9.3%	21,692 $1.82 Million
Q1 2021 May 06, 2021	BUY	$76.02 - $100.5 $480,066 - $634,657	6,315 Added 46.67%	19,846 $1.61 Million
Q4 2020 Feb 02, 2021	BUY	$80.74 - $97.7 $328,854 - $397,932	4,073 Added 43.06%	13,531 $1.18 Million
Q3 2020 Nov 13, 2020	BUY	$85.07 - $109.69 $366,481 - $472,544	4,308 Added 83.65%	9,458 $848,000
Q2 2020 Aug 10, 2020	BUY	$74.18 - $108.93 $44,285 - $65,031	597 Added 13.11%	5,150 $535,000
Q1 2020 May 01, 2020	BUY	$63.18 - $85.97 $287,658 - $391,421	4,553 New	4,553 $333,000
Q4 2018 Feb 11, 2019	SELL	$58.5 - $69.94 $877 - $1,049	-15 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$61.75 - $74.23 $926 - $1,113	15 New	15 $1,000

Others Institutions Holding INCY

# of Institutions

657

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.4B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Girard Partners Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Girard Partners Ltd. with notifications on news.

Account

Girard Partners Ltd. Incyte Corp Transaction History